Abstract
The aim of this study was to assess monocyte/macrophage function, as defined by lipopolysaccharide (LPS)-induced production of tumour necrosis factor (TNF)-α, interleukin (IL)-10 and interferon (IFN)-γ by stimulated whole blood cultures in patients with colorectal carcinoma before and after surgical resection. Forty colorectal cancer patients prior to surgery and 31 healthy controls were studied. Heparinized venous blood was taken from colorectal cancer patients prior to surgery and from healthy controls. Serial samples were obtained at least 3–6 weeks post-operatively. Blood was stimulated with LPS for 24 h and supernatants were assayed for TNF-α, IFN-γ and IL-10 by enzyme-linked immunosorbent assay. LPS-induced production of TNF-α and of IFN-γ was reduced in patients with colorectal carcinoma compared to controls (TNF-α, 11 269 pg ml−1{12 598}; IFN-γ, 0.00 pg ml−1{226}; median {IQR}) (TNF-α, 20 576 pg ml−1{11 637}, P< 0.0001; IFN-γ, 1048 {2428}, P = 0.0051, Mann–Whitney U -test). Production in patients after surgery had increased (TNF-α: 17 620 pg ml−1{7986}; IFN-γ: 410 pg ml−1{2696}; mean {s.d.}) and were no longer significantly reduced when compared to controls (TNF-α, P = 0.28; IFN-γ, P = 0.76). Production of TNF-α and IFN-γ prior to surgery were reduced to a greater extent in patients with Dukes' stage C tumours compared to those with Dukes' stage A and B stage. There was no difference in IL-10 production between any group. Monocytes/macrophages from patients with colorectal carcinoma are refractory to LPS stimulation as reflected by reduction in TNF-α and IFN-γ production and this is more pronounced in patients with advanced stage tumours. This suppression is not mediated by IL-10 and disappears following surgical resection of the tumour. This provides evidence for tumour induced suppression of immune function in patients with colorectal cancer and identifies a potential therapeutic avenue. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arista M, Callopoli A, De Franceschi L, Santini A, Schiratti M, Di Filippo F and Gandolfo GM (1994) Flow cytometric study of lymphocyte subsets in patients at different stage of colorectal carcinoma. Dis Colon Rectum 37: S30–S34
Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli S, Fossati V, Fumagalli L, Brivio F and Tancini G (1995) A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates. Oncology 52: 243–245
Brivio F, Lissoni P, Alderi G, Barni S, Lavorato F and Fumagalli L (1996) Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53: 263–268
Cole W and Humphrey L (1985) Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Ann Surg 202: 9–20
Darcy P, Kershaw M, Trapani J and Smyth M (1998) Expression in cytotoxic T lymphocytes of a single chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma. Eur J Immunol 28: 1663–1672
Elsasser Beile U, von Kleist S, Fischer R and Monting JS (1992) Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal 6: 311–314
Hammer J, Nielsen H, Moesgaard F and Kehlet H (1992) Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res 24: 133–137
Hrouda D, Muir G and Dalgleish A (1997) The role of immunotherapy for urological tumours. Br J Urol 79: 307–316
King J, Caplehorn J, Ross W and Morris D (1997) High serum carcinembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival. Br J Surg 84: 1382–1385
McMillan DC, Fyffe GD, Wotherspoon HA, Cooke TG and McArdle CS (1997) Prospective study of circulating T-lymphocyte subpopulations and disease progression in colorectal cancer. Dis Colon Rectum 40: 1068–1071
Medical Oncology Society (1979) Delayed cutaneous hypersensitivity (DCH) reactions in normal populations by multitest; effect of sex and age. 5th Annual Meeting of the Medical Oncology Society, 1–3 December, Nice, France, Springer: Berlin
Mittelman A, Huberman M, Puccio C, Fallon B, Tessitore J, Savona S, Eyre R, Gafney E, Wick M and Skelos A (1990) A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer and malignant melanoma. Cancer 66: 664–669
O'Hara R, Greenman J, Drew P, McDonald AW, Duthie GS, Lee PW and Monson JR (1998) Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer. Dis Colon Rectum 41: 460–463
Pullyblank A, Guillou P and Monson J (1991) Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody dependent cell-mediated cytotoxity. Br J Cancer 72: 601–606
Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H and Pichlmayr R (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group [see comments]. Lancet 343: 1177–1183
Tancini G, Barni S, Rescaldani R, Fiorelli G, Viviani S and Lissoni P (1990) Analysis of T helper and suppressor lymphocyte subsets in relation to the clinical stage of solid neoplasms. Oncology 47: 381–384
Tsutsui S, Morita M, Kuwano H, Matsuda H, Mori M, Okamura S and Sugimachi K (1992) Influence of preoperative treatment and surgical operation on immune function of patients with oesophageal carcinoma. J Surg Oncol 49: 176–181
Author information
Authors and Affiliations
Additional information
This work has been presented as an abstract at the British Society of Gastroenterology, Harrogate, March 1998, and the Digestive Diseases Week, New Orleans, May 1998.
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Heriot, A., Marriott, J., Cookson, S. et al. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer 82, 1009–1012 (2000). https://doi.org/10.1054/bjoc.1999.1034
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.1034
Keywords
This article is cited by
-
Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process
Clinical & Experimental Metastasis (2018)
-
Malignancy is a risk factor for postoperative infectious complications after elective colorectal resection
International Journal of Colorectal Disease (2016)
-
Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance
British Journal of Cancer (2014)
-
Dendritic Cell Cancer Vaccines for Treatment of Colon Cancer
Current Colorectal Cancer Reports (2014)
-
Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients
Investigational New Drugs (2012)
